Stryker Corp (SYK)
338.34
+3.43
(+1.02%)
USD |
NYSE |
Apr 24, 14:06
Stryker Free Cash Flow (Quarterly): 1.383B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.383B |
September 30, 2023 | 902.00M |
June 30, 2023 | 536.00M |
March 31, 2023 | 315.00M |
December 31, 2022 | 815.00M |
September 30, 2022 | 751.00M |
June 30, 2022 | 386.00M |
March 31, 2022 | 84.00M |
December 31, 2021 | 794.00M |
September 30, 2021 | 803.00M |
June 30, 2021 | 772.00M |
March 31, 2021 | 369.00M |
December 31, 2020 | 1.072B |
September 30, 2020 | 760.00M |
June 30, 2020 | 511.00M |
March 31, 2020 | 447.00M |
December 31, 2019 | 536.00M |
September 30, 2019 | 466.00M |
June 30, 2019 | 349.00M |
March 31, 2019 | 191.00M |
December 31, 2018 | 892.00M |
September 30, 2018 | 478.00M |
June 30, 2018 | 492.00M |
March 31, 2018 | 176.00M |
December 31, 2017 | 493.00M |
Date | Value |
---|---|
September 30, 2017 | -63.00M |
June 30, 2017 | 519.00M |
March 31, 2017 | 12.00M |
December 31, 2016 | 515.00M |
September 30, 2016 | 384.00M |
June 30, 2016 | 379.00M |
March 31, 2016 | 147.00M |
December 31, 2015 | 674.00M |
September 30, 2015 | -586.00M |
June 30, 2015 | 289.00M |
March 31, 2015 | 334.00M |
December 31, 2014 | 618.00M |
September 30, 2014 | 476.00M |
June 30, 2014 | 316.00M |
March 31, 2014 | 139.00M |
December 31, 2013 | 616.00M |
September 30, 2013 | 579.00M |
June 30, 2013 | 309.00M |
March 31, 2013 | 187.00M |
December 31, 2012 | 547.00M |
September 30, 2012 | 511.00M |
June 30, 2012 | 406.00M |
March 31, 2012 | -17.00M |
December 31, 2011 | 563.00M |
September 30, 2011 | 389.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
84.00M
Minimum
Mar 2022
1.383B
Maximum
Dec 2023
634.26M
Average
536.00M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
Boston Scientific Corp | 690.00M |
Haemonetics Corp | -22.83M |
Abbott Laboratories | 2.283B |
Zimmer Biomet Holdings Inc | 525.60M |
Edwards Lifesciences Corp | 35.00M |